fluconazole has been researched along with Sporotrichosis in 24 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Sporotrichosis: The commonest and least serious of the deep mycoses, characterized by nodular lesions of the cutaneous and subcutaneous tissues. It is caused by inhalation of contaminated dust or by infection of a wound with SPOROTHRIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty patients with documented sporotrichosis were treated with 200-800 mg of fluconazole daily." | 9.08 | Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. ( Cloud, GA; Dismukes, WE; Greenfield, RA; Kauffman, CA; McKinsey, DS; Pappas, PG; Perfect, JR; Thomas, CJ, 1996) |
| "Eighty-eight immunocompetent patients with deep mycoses from eight countries were evaluated with the same protocol for efficacy of fluconazole monotherapy." | 9.07 | A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. ( Arathoon, EG; Borelli, D; Bran, JL; Castro, LG; Diaz, M; Franco, L; Montero-Gei, F; Negroni, R; Restrepo, A; Sampaio, SA, 1992) |
| "We report three cases of sporotrichosis successfully treated with oral fluconazole." | 7.68 | Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. ( Belda Júnior, W; Castro, LG; Cucé, LC; Sampaio, SA; Stevens, DA, 1993) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 7.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Cutaneous sporotrichosis is clinically divided into two main types: lymphocutaneous and fixed plaque type." | 5.31 | Case report. An unusual case of cutaneous sporotrichosis and its response to weekly fluconazole. ( Akhyani, M; Arad, S; Ataii, L; Daneshpazhooh, M; Ghodsi, SZ; Naraghi, Z; Shams, S, 2000) |
| "Thirty patients with documented sporotrichosis were treated with 200-800 mg of fluconazole daily." | 5.08 | Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. ( Cloud, GA; Dismukes, WE; Greenfield, RA; Kauffman, CA; McKinsey, DS; Pappas, PG; Perfect, JR; Thomas, CJ, 1996) |
| "Eighty-eight immunocompetent patients with deep mycoses from eight countries were evaluated with the same protocol for efficacy of fluconazole monotherapy." | 5.07 | A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group. ( Arathoon, EG; Borelli, D; Bran, JL; Castro, LG; Diaz, M; Franco, L; Montero-Gei, F; Negroni, R; Restrepo, A; Sampaio, SA, 1992) |
| "We report three cases of sporotrichosis successfully treated with oral fluconazole." | 3.68 | Successful treatment of sporotrichosis with oral fluconazole: a report of three cases. ( Belda Júnior, W; Castro, LG; Cucé, LC; Sampaio, SA; Stevens, DA, 1993) |
| " Itraconazole was superior to fluconazole in candidosis, cryptococcosis, sporotrichosis and aspergillosis, and to amphotericin B and to flucytosine in candidosis, cryptococcosis and aspergillosis." | 3.68 | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. ( Van Cutsem, J, 1992) |
| "Feline sporotrichosis has been reported in Malaysia since the 1990's." | 2.55 | The Current Status of Feline Sporotrichosis in Malaysia. ( Siew, HH, 2017) |
| "Pulmonary sporotrichosis is rare and responds poorly to treatment." | 1.33 | Pulmonary Sporothrix schenckii infection in a HIV positive child. ( Behets, F; Callens, SF; Colebunders, R; Kitetele, F; Lelo, P; Lukun, P; Van Rie, A, 2006) |
| "Cutaneous sporotrichosis is clinically divided into two main types: lymphocutaneous and fixed plaque type." | 1.31 | Case report. An unusual case of cutaneous sporotrichosis and its response to weekly fluconazole. ( Akhyani, M; Arad, S; Ataii, L; Daneshpazhooh, M; Ghodsi, SZ; Naraghi, Z; Shams, S, 2000) |
| "Medical treatments for chromoblastomycosis has been disappointing, while lymphocutaneous sporotrichosis usually responds well to iodides." | 1.29 | Successful treatment of subcutaneous mycoses with fluconazole: a report of two cases. ( Cheng, NC; Kuo, BI; Lee, WS; Liu, CE; Liu, CY; Yang, SP, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (45.83) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarado-Ramírez, E | 1 |
| Torres-Rodríguez, JM | 1 |
| Marimon, R | 1 |
| Serena, C | 1 |
| Gené, J | 1 |
| Cano, J | 1 |
| Guarro, J | 1 |
| Indoung, S | 1 |
| Chanchayanon, B | 1 |
| Chaisut, M | 1 |
| Buapeth, KO | 1 |
| Morteh, R | 1 |
| Jantrakajorn, S | 1 |
| Song, Y | 1 |
| Li, S | 1 |
| Shi, Y | 1 |
| Zhao, L | 1 |
| Cui, Y | 2 |
| Yao, L | 1 |
| Zhen, Y | 1 |
| Chen, R | 1 |
| Siew, HH | 1 |
| Ramírez Soto, MC | 1 |
| Landell, MF | 1 |
| Stopiglia, CD | 1 |
| Billodre, RG | 1 |
| Heidrich, D | 1 |
| Sorrentino, JM | 1 |
| Vainstein, MH | 1 |
| Scroferneker, ML | 1 |
| Valente, P | 1 |
| Hampton, DE | 1 |
| Adesina, A | 1 |
| Chodosh, J | 1 |
| Sharma, NL | 2 |
| Mahajan, VK | 2 |
| Verma, N | 1 |
| Thakur, S | 1 |
| Kimyai-Asadi, A | 1 |
| Jih, MH | 1 |
| Began, DM | 1 |
| Mully, TW | 1 |
| Shupack, JL | 1 |
| Kamino, H | 1 |
| Sharma, RC | 1 |
| Gupta, ML | 1 |
| Garg, G | 1 |
| Kanga, AK | 1 |
| Callens, SF | 1 |
| Kitetele, F | 1 |
| Lukun, P | 1 |
| Lelo, P | 1 |
| Van Rie, A | 1 |
| Behets, F | 1 |
| Colebunders, R | 1 |
| Donabedian, H | 1 |
| O'Donnell, E | 1 |
| Olszewski, C | 1 |
| MacArthur, RD | 1 |
| Budd, N | 1 |
| Castro, LG | 2 |
| Belda Júnior, W | 1 |
| Cucé, LC | 1 |
| Sampaio, SA | 2 |
| Stevens, DA | 1 |
| Kauffman, CA | 1 |
| Pappas, PG | 1 |
| McKinsey, DS | 1 |
| Greenfield, RA | 1 |
| Perfect, JR | 1 |
| Cloud, GA | 1 |
| Thomas, CJ | 1 |
| Dismukes, WE | 1 |
| Yang, SP | 1 |
| Liu, CY | 1 |
| Cheng, NC | 1 |
| Lee, WS | 1 |
| Liu, CE | 1 |
| Kuo, BI | 1 |
| Wu, S | 1 |
| Guo, N | 1 |
| Hou, Y | 1 |
| Vieira-Dias, D | 1 |
| Sena, CM | 1 |
| Oréfice, F | 1 |
| Tanure, MA | 1 |
| Hamdan, JS | 1 |
| Goldani, LZ | 1 |
| Aquino, VR | 1 |
| Dargél, AA | 1 |
| Ghodsi, SZ | 1 |
| Shams, S | 1 |
| Naraghi, Z | 1 |
| Daneshpazhooh, M | 1 |
| Akhyani, M | 1 |
| Arad, S | 1 |
| Ataii, L | 1 |
| Van Cutsem, J | 1 |
| Penn, CC | 1 |
| Goldstein, E | 1 |
| Bartholomew, WR | 1 |
| Diaz, M | 1 |
| Negroni, R | 1 |
| Montero-Gei, F | 1 |
| Borelli, D | 1 |
| Restrepo, A | 1 |
| Franco, L | 1 |
| Bran, JL | 1 |
| Arathoon, EG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00004938] | Phase 2 | 30 participants | Interventional | 1996-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for fluconazole and Sporotrichosis
| Article | Year |
|---|---|
The Current Status of Feline Sporotrichosis in Malaysia.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; Drug Resistance, Fungal; Fluconazole | 2017 |
Sporotrichosis in the Ocular Adnexa: 21 Cases in an Endemic Area in Peru and Review of the Literature.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; Conjunctival Diseases; Dacryocy | 2016 |
Ocular and concomitant cutaneous sporotrichosis.
Topics: Amphotericin B; Anterior Chamber; Brazil; Child; Eye Infections, Fungal; Female; Fluconazole; Humans | 1997 |
2 trials available for fluconazole and Sporotrichosis
| Article | Year |
|---|---|
Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole.
Topics: Adult; Antifungal Agents; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Male; Middl | 1996 |
A Pan-American 5-year study of fluconazole therapy for deep mycoses in the immunocompetent host. Pan-American Study Group.
Topics: Adolescent; Adult; Aged; Chromoblastomycosis; Coccidioidomycosis; Female; Fluconazole; Fungi; Histop | 1992 |
19 other studies available for fluconazole and Sporotrichosis
| Article | Year |
|---|---|
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazo | 2007 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Sp | 2008 |
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazol | 2022 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity T | 2021 |
Evaluation of the origin of a sample of Sporothrix schenckii that caused contamination of a researcher in Southern Brazil.
Topics: Brazil; Fluconazole; Humans; Ketoconazole; Laboratories; Male; Microbial Sensitivity Tests; Potassiu | 2011 |
Conjunctival sporotrichosis in the absence of antecedent trauma.
Topics: Adult; Antifungal Agents; Conjunctiva; Conjunctivitis; Diagnosis, Differential; Eye Infections, Fung | 2002 |
Cutaneous sporotrichosis: an unusual clinico-pathologic and therapeutic presentation.
Topics: Adult; Antifungal Agents; Facial Dermatoses; Female; Fluconazole; Humans; Potassium Iodide; Sporothr | 2003 |
A 63-year-old man with chronic penile ulcers.
Topics: Antifungal Agents; Biopsy; Fluconazole; Humans; Male; Middle Aged; Penile Diseases; Skin; Sporotrich | 2003 |
Cutaneous sporotrichosis in Himachal Pradesh, India.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Child; Female; Fluconazole; Humans; I | 2005 |
Pulmonary Sporothrix schenckii infection in a HIV positive child.
Topics: Antifungal Agents; Child; Democratic Republic of the Congo; Fluconazole; HIV Seropositivity; Humans; | 2006 |
Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Fluconazole; Humans; Male; Meningoencephalitis; Sporot | 1994 |
Successful treatment of sporotrichosis with oral fluconazole: a report of three cases.
Topics: Administration, Oral; Adult; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Age | 1993 |
Successful treatment of subcutaneous mycoses with fluconazole: a report of two cases.
Topics: Adult; Aged; Antifungal Agents; Chromoblastomycosis; Fluconazole; Humans; Male; Sporotrichosis | 1995 |
Effects of systemic fluconazole therapy on in vitro adhesion of Candida albicans to buccal epithelial cells and changes of the cell surface proteins of the epithelial cells.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Oral; Epithelium; Female; Fluconazole; Huma | 1996 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Female; Fluconazole; Humans; Meningitis, | 1999 |
Case report. An unusual case of cutaneous sporotrichosis and its response to weekly fluconazole.
Topics: Aged; Antifungal Agents; Drug Administration Schedule; Female; Fluconazole; Humans; Sporotrichosis; | 2000 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy | 1992 |
Sporothrix schenckii meningitis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dermatomycoses; Fluconazole; Humans; M | 1992 |